Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de James Scott
Age : 49
Country of residence : Unknown
Linked companies : Microsoft Corporation - Stellantis N.V.

Biography of James Scott 
Currently, James Kevin Scott is Chief Technology Officer & Executive VP at Microsoft Corp. He is also on the board of Anita Borg Institute for Women & Technology, Relativity ODA LLC, The Scott Foundation and Stellantis NV. He previously held the position of Senior Vice President-Engineering & Operations at LinkedIn Corp., Vice President-Engineering at AdMob, Inc., Engineering Manager at Google LLC and Member-Professions Board at Association for Computing Machinery, Inc. He received a graduate degree from Wake Forest University, an undergraduate degree from Lynchburg College and a doctorate from the University of Virginia.


Current positions of James Scott 
James Scott : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/06MARTIN SORRELL : Sorrell's S4 sees good 2022 after publishing delayed results
RE
More news


© 2022 People and Ownership :   
James Scott : Connections 


Latest news about James Scott 
05/13TRANSCRIPT : PEXA Group Limited - Analyst/Investor Day
CI
05/05TRANSCRIPT : CytomX Therapeutics, Inc., Q1 2022 Earnings Call, May 05, 2022
CI
05/03TRANSCRIPT : Incyte Corporation, Q1 2022 Earnings Call, May 03, 2022
CI
04/28TRANSCRIPT : Gilead Sciences, Inc., Q1 2022 Earnings Call, Apr 28, 2022
CI
04/27TRANSCRIPT : Amgen Inc., Q1 2022 Earnings Call, Apr 27, 2022
CI
04/13Laird Superfood, Inc. Announces Resignation of James Scott McGuire as Chief Operating Officer
CI
04/11INSIDER SELL : Lindsay
MT
More news